Search

Your search keyword '"Udager, Aaron M"' showing total 467 results

Search Constraints

Start Over You searched for: Author "Udager, Aaron M" Remove constraint Author: "Udager, Aaron M"
467 results on '"Udager, Aaron M"'

Search Results

2. Integrative multi-region molecular profiling of primary prostate cancer in men with synchronous lymph node metastasis

3. Transcriptional profiling of matched patient biopsies clarifies molecular determinants of enzalutamide-induced lineage plasticity.

4. Integrative Drug Screening and Multiomic Characterization of Patient-derived Bladder Cancer Organoids Reveal Novel Molecular Correlates of Gemcitabine Response

7. Somatic SLC30A1 mutations altering zinc transporter ZnT1 cause aldosterone-producing adenomas and primary aldosteronism

9. Precision medicine-based platform to guide the treatment of EML4-ALK driven lung cancers and other NSCLC in real time.

11. Somatic mutations of CADM1 in aldosterone-producing adenomas and gap junction-dependent regulation of aldosterone production

18. Development of a Whole-urine, Multiplexed, Next-generation RNA-sequencing Assay for Early Detection of Aggressive Prostate Cancer

20. Molecular Characterization of Clear Cell Renal Cell Carcinoma Reveals Prognostic Significance of Epithelial-mesenchymal Transition Gene Expression Signature

21. Double somatic mutations in CTNNB1 and GNA11 in an aldosterone-producing adenoma

22. Multifocal, Asymmetric Bilateral Primary Aldosteronism Cannot be Excluded by Strong Adrenal Vein Sampling Lateralization: An International Retrospective Cohort Study

33. A Novel RNA In Situ Hybridization Assay for the Long Noncoding RNA SChLAP1 Predicts Poor Clinical Outcome After Radical Prostatectomy in Clinically Localized Prostate Cancer

34. Double somatic mutations in CTNNB1 and GNA11 in an aldosterone-producing adenoma.

35. Analysis of the Tumor Immune Microenvironment (TIME) in Clear Cell Renal Cell Carcinoma (ccRCC) Reveals an M0 Macrophage-Enriched Subtype: An Exploration of Prognostic and Biological Characteristics of This Immune Phenotype

37. International consensus statement on allergy and rhinology: Sinonasal tumors

38. Direct cellular reprogramming enables development of viral T antigen-driven Merkel cell carcinoma in mice

39. De novo neuroendocrine transdifferentiation in primary prostate cancer–a phenotype associated with advanced clinico-pathologic features and aggressive outcome

40. Detection of 6 TFEB-amplified renal cell carcinomas and 25 renal cell carcinomas with MITF translocations: systematic morphologic analysis of 85 cases evaluated by clinical TFE3 and TFEB FISH assays

41. Sinonasal Papillomas and Carcinomas: A Contemporary Update With Review of an Emerging Molecular Classification

44. Precision medicine-based platform to guide the treatment of EML4-ALK fusion lung cancers and other non-small cell lung cancers.

47. Programmed Death-ligand 1 Expression in Upper Tract Urothelial Carcinoma

50. Development and application of a precision cell-free DNA (cfDNA) minimal residual disease (MRD) test to enable optimized treatment selection in patients with genitourinary (GU) cancers.

Catalog

Books, media, physical & digital resources